definiens: shall mean, withregard to [COMPANY] as the Conducting Party or Ono, allowing the applicable Regulatory Authority in a country tohave access to relevant information ( by cross - reference, incorporation by reference or otherwise ) contained inRegulatory Documentation ( and any data contained therein ) filed with such Regulatory Authority with respectto the [COMPANY] Compound ( and, in the case of [COMPANY] as the Non - Conducting Party, the Right to Cross - Reference the Combined Therapy IND ), only to the extent necessary for the conduct of a Combined TherapyTrial in such country or as otherwise expressly permitted or required under the Agreement and/or thisSupplement to enable [COMPANY] to exercise its rights or perform its obligations under the Agreement, the OnoTerritory Supplemental Agreement and/or this Supplement and to enable Ono to exercise its rights or performits obligations under the Ono Territory Supplemental Agreement, and, except as to information contained inthe Combined Therapy IND relating to the Combined Therapy, without the disclosure of such information toBMS or Ono . ”5